$SNSE stock has now fallen 10% today, according to our price data from Polygon. There has been approximately $2,608,075 of trading volume.
Here is what we see in our data on $SNSE (you can track the company live on Quiver's $SNSE stock page):
$SNSE Insider Trading Activity
$SNSE insiders have traded $SNSE stock on the open market 16 times in the past 6 months. Of those trades, 0 have been purchases and 16 have been sales.
Here’s a breakdown of recent trading of $SNSE stock by insiders over the last 6 months:
- BIOPHARMA INC CAMBRIAN has made 0 purchases and 8 sales selling 27,907 shares for an estimated $287,264.
- JAMES PEYER has made 0 purchases and 8 sales selling 27,907 shares for an estimated $287,264.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$SNSE Hedge Fund Activity
We have seen 2 institutional investors add shares of $SNSE stock to their portfolio, and 3 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC removed 29,090 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $274,900
- RENAISSANCE TECHNOLOGIES LLC added 10,416 shares (+inf%) to their portfolio in Q3 2025, for an estimated $98,431
- UBS GROUP AG removed 1,267 shares (-59.2%) from their portfolio in Q3 2025, for an estimated $11,973
- RAYMOND JAMES FINANCIAL INC removed 700 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $6,614
- BANK OF AMERICA CORP /DE/ added 48 shares (+8.2%) to their portfolio in Q3 2025, for an estimated $453
- BNP PARIBAS FINANCIAL MARKETS added 0 shares (+0.0%) to their portfolio in Q3 2025, for an estimated $0
- JPMORGAN CHASE & CO added 0 shares (+0.0%) to their portfolio in Q3 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
You can track data on $SNSE on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
